View of Toward Precision Oncology in Ovarian Cancer: Dual PD-L1 and CD44 Biomarker Profiling for Recurrence Risk Assessment

Return to Article Details Toward Precision Oncology in Ovarian Cancer: Dual PD-L1 and CD44 Biomarker Profiling for Recurrence Risk Assessment Download Download PDF